Our finding that PLK1 leads to the decrease of PHGDH, thus decreasing of SSP in prostate cancer, which is reminiscent of checking inosine monophosphate (IMP), the downstream purine from glucose and one carbon metabolism. This evidence concerns the gene PLK1 and prostate cancer.